Neogen Corporation (NEOG) — Form 10-Q Summary
Business context and reporting period
Quarterly report for the third quarter and first nine months of fiscal 2022, ended February 28, 2022. Neogen develops and sells food safety and animal safety products and services. Unless otherwise noted, financial amounts below are in millions of dollars.
Financial results and liquidity
| Metric | Q3 FY2022 | Q3 FY2021 | Nine months FY2022 | Nine months FY2021 |
|---|---|---|---|---|
| Revenue | $128.2 | $116.7 | $387.1 | $341.0 |
| Gross margin | $57.4; 44.8% | $53.8; 46.1% | $178.0; 46.0% | $157.4; 46.1% |
| Operating income | $6.4 | $15.8 | $40.6 | $53.9 |
| Net income | $5.4 | $13.4 | $33.3 | $45.1 |
| Diluted earnings per share | $0.05 | $0.12 | $0.31 | $0.42 |
| Cash from operations | Not presented quarterly | $47.6 | $59.1 |
- Quarterly revenue rose 10%; organic sales growth was 6%. Nine-month revenue rose 13%; organic sales growth was 10%.
- Food Safety revenue increased 7% in Q3 and 13% year to date; Animal Safety revenue increased 12% and 14%, respectively.
- Operating expenses increased 34% in Q3 and 33% year to date. They included 3M transaction-related legal, consulting, and professional fees of $10.6 million in Q3 and $19.9 million year to date. Excluding those fees, management reported operating income of $17.0 million for Q3 and $60.5 million year to date.
- Management attributed lower gross margin primarily to Animal Safety product mix and higher raw material and freight costs. Pricing actions were taken where appropriate.
- At February 28, cash and cash equivalents were $42.9 million and marketable securities were $335.6 million, together $378.4 million, versus $381.1 million at May 31, 2021. Current assets were $609.6 million and current liabilities $65.7 million.
- Operating cash flow was $47.6 million. Investing activities used $80.1 million, including $38.2 million for acquisitions and $11.9 million for capital and other non-current assets. Cash and cash equivalents declined $32.7 million during the nine-month period.
- No borrowings were outstanding on the $15 million revolving credit facility; the company reported compliance with its financial covenants. Total liabilities were $105.7 million. The filing describes no other funded debt balance.
Material changes and management commentary
- Revenue growth included acquisitions and organic gains. Stronger areas included veterinary instruments and disposables, culture media, and genomics services. Some food safety diagnostic demand remained affected by weaker restaurant and institutional food-service activity.
- COVID-19 continued to affect demand, supply availability, shipping costs, staffing, labor costs, and customer access. Management said the effects were expected to continue through at least the end of the fiscal year, with the overall impact uncertain.
- Neogen completed acquisitions of CAPInnoVet, Delf (U.K.)/Abbott Analytical, and Genetic Veterinary Sciences during the period. The filing says acquired businesses’ revenues and net income were not material and were not separately disclosed.
- In December 2021, Neogen agreed to combine with 3M’s Food Safety business through a Reverse Morris Trust transaction. The filing anticipated closing in calendar Q3 2022. Funding was expected to include Neogen common stock issued to 3M shareholders and approximately $1 billion of borrowing; existing cash and credit capacity alone would not fund the transaction.
- Neogen does not provide financial forecasts. Management stated existing liquidity and expected operating cash flows were sufficient for activities through the remainder of the current fiscal year, apart from the planned 3M transaction.
Risks, contingencies, and unusual items
- Newly highlighted international risks include geopolitical disruption, sanctions, inflation, currency movements, trade restrictions, transport and labor disruption, and compliance risks. Neogen said it discontinued sales into Russia following the invasion of Ukraine and related sanctions; further sanctions could affect input availability, sales, and earnings.
- OFAC is investigating transactions involving parties in Iran. Neogen is cooperating, reviewing potential license coverage, and has enhanced compliance measures. It had recorded a $0.6 million reserve for potential fines or penalties and said it believed the reserve adequate; the outcome remains uncertain.
- Environmental remediation at the Randolph, Wisconsin facility carried an estimated remaining liability of $0.916 million. A proposed pilot study could lead to a change in remediation strategy and higher future costs.
- Unrealized losses on marketable securities were $1.856 million at February 28, 2022; the filing records fair-value changes in other comprehensive income.
- Management reported disclosure controls were effective and no material changes in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Progress, financing terms, expected closing, and integration risks for the 3M Food Safety transaction, including the anticipated approximately $1 billion borrowing.
- Whether organic growth and margins improve as COVID-related demand and supply disruptions ease, and whether pricing offsets ongoing input, freight, and labor costs.
- Acquisition integration and performance, particularly the contribution of recent acquisitions to reported revenue growth and goodwill/intangible balances.
- Developments in the OFAC investigation and Wisconsin remediation plan, including possible changes to recorded liabilities.
- Exposure to international markets, foreign exchange movements, Russia-related sanctions, and marketable-security valuation changes.